Trial Profile
Prophylactic Ranibizumab in the fellow eye in patients with wet type Age Related Macular Degeneration
Status:
Not yet recruiting
Phase of Trial:
Phase III/IV
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 02 Jun 2014 New trial record